Trial Outcomes & Findings for Nudging Provider Adoption of Clinical Decision Support (NCT NCT05203185)

NCT ID: NCT05203185

Last Updated: 2023-06-26

Results Overview

The tool is considered adopted during a patient visit if the provider accepted the recommendation given by the PERK tool (i.e., a D-dimer was recommended and ordered or a CT pulmonary angiogram (CTPA) was recommended and ordered). This outcome measure is assessed using electronic health record (EHR) data from the patient visit.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1612 participants

Primary outcome timeframe

Up to Month 6

Results posted on

2023-06-26

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention Site - Providers
Providers at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Providers
Providers at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Intervention Site - Patients
Patients at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Patients
Patients at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Overall Study
STARTED
49
35
793
735
Overall Study
COMPLETED
49
35
793
735
Overall Study
NOT COMPLETED
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Sex data were not collected from study participants.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Site - Providers
n=49 Participants
Providers at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Providers
n=35 Participants
Providers at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Intervention Site - Patients
n=793 Participants
Patients at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Patients
n=735 Participants
Patients at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Total
n=1612 Participants
Total of all reporting groups
Age, Continuous
38 years
n=49 Participants
35 years
n=35 Participants
65 years
n=793 Participants
64 years
n=735 Participants
51 years
n=1612 Participants
Sex: Female, Male
Female
0 Participants
Sex data were not collected from study participants.
Sex: Female, Male
Male
0 Participants
Sex data were not collected from study participants.
Ethnicity (NIH/OMB)
Hispanic or Latino
69 Participants
n=793 Participants • Ethnicity data were not collected from Provider participants.
32 Participants
n=735 Participants • Ethnicity data were not collected from Provider participants.
101 Participants
n=1528 Participants • Ethnicity data were not collected from Provider participants.
Ethnicity (NIH/OMB)
Not Hispanic or Latino
673 Participants
n=793 Participants • Ethnicity data were not collected from Provider participants.
617 Participants
n=735 Participants • Ethnicity data were not collected from Provider participants.
1290 Participants
n=1528 Participants • Ethnicity data were not collected from Provider participants.
Ethnicity (NIH/OMB)
Unknown or Not Reported
51 Participants
n=793 Participants • Ethnicity data were not collected from Provider participants.
86 Participants
n=735 Participants • Ethnicity data were not collected from Provider participants.
137 Participants
n=1528 Participants • Ethnicity data were not collected from Provider participants.
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=793 Participants • Race data were not collected from Provider participants.
0 Participants
n=735 Participants • Race data were not collected from Provider participants.
0 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
Asian
14 Participants
n=793 Participants • Race data were not collected from Provider participants.
32 Participants
n=735 Participants • Race data were not collected from Provider participants.
46 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=793 Participants • Race data were not collected from Provider participants.
0 Participants
n=735 Participants • Race data were not collected from Provider participants.
0 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
Black or African American
42 Participants
n=793 Participants • Race data were not collected from Provider participants.
435 Participants
n=735 Participants • Race data were not collected from Provider participants.
477 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
White
618 Participants
n=793 Participants • Race data were not collected from Provider participants.
146 Participants
n=735 Participants • Race data were not collected from Provider participants.
764 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
More than one race
0 Participants
n=793 Participants • Race data were not collected from Provider participants.
0 Participants
n=735 Participants • Race data were not collected from Provider participants.
0 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Race (NIH/OMB)
Unknown or Not Reported
119 Participants
n=793 Participants • Race data were not collected from Provider participants.
122 Participants
n=735 Participants • Race data were not collected from Provider participants.
241 Participants
n=1528 Participants • Race data were not collected from Provider participants.
Region of Enrollment
United States
49 Participants
n=49 Participants
35 Participants
n=35 Participants
793 Participants
n=793 Participants
735 Participants
n=735 Participants
1612 Participants
n=1612 Participants

PRIMARY outcome

Timeframe: Up to Month 6

The tool is considered adopted during a patient visit if the provider accepted the recommendation given by the PERK tool (i.e., a D-dimer was recommended and ordered or a CT pulmonary angiogram (CTPA) was recommended and ordered). This outcome measure is assessed using electronic health record (EHR) data from the patient visit.

Outcome measures

Outcome measures
Measure
Intervention Site - Patients and Providers
n=793 Patient Visits
Patients and Providers at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Patients and Providers
n=735 Patient Visits
Patients and Providers at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool
39.11 Percentage of Patient Visits
20.66 Percentage of Patient Visits

SECONDARY outcome

Timeframe: Up to Month 6

Monitored using EHR reporting data. Calculated as the percentage of CTPA tests ordered to evaluate for PE that are positive for PE.

Outcome measures

Outcome measures
Measure
Intervention Site - Patients and Providers
n=707 PE-Designated CTPA Tests
Patients and Providers at the site assigned to the intervention: Full time employed Emergency Department providers will use the new CDS tool, Pulmonary Embolism Risk Kalculator (PERK), which includes nudges to improve use and will be integrated into the electronic medical record and will be accessible for 6 months Pulmonary Embolism Risk Kalculator (PERK): Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. Nudges will be to the PE CALC CDS tool to develop the new CDS tool, PERK.
No Intervention Site - Patients and Providers
n=641 PE-Designated CTPA Tests
Patients and Providers at the site assigned to no intervention: Full time employed Emergency Department providers used a CDS tool, Pulmonary Embolism Calculator (PE CALC), without nudges to improve use, to reduce unnecessary imaging in the diagnosis of pulmonary embolism (PE) in the emergency department (ED).
Percentage of PE-Designated CTPA Tests That Are Positive for PE
26.45 Percentage of PE-Designated CTPA Tests
10.76 Percentage of PE-Designated CTPA Tests

Adverse Events

Intervention Site - Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No Intervention Site - Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Safiya Richardson, MD, MPH

NYU Langone Health

Phone: 212-263-8313

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place